Ticker Details
Relmada Therapeutics, Inc.
IPO Date:	June 16, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$798.2M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 3.89%
Avg Daily Range (30 D):	$0.21 | 3.39%
Avg Daily Range (90 D):	$0.19 | 3.92%

Institutional Daily Volume
Avg Daily Volume:	.38M
Avg Daily Volume (30 D):	2.14M
Avg Daily Volume (90 D):	1.16M

Trade Size
Avg Trade Size (Sh.):	125
Avg Trade Size (Sh.) (30 D):	91
Avg Trade Size (Sh.) (90 D):	96

Institutional Trades
Total Institutional Trades:	388
Avg Institutional Trade:	$2.17M
Avg Institutional Trade (30 D):	$1.73M
Avg Institutional Trade (90 D):	$1.97M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.3M
Avg Closing Trade (30 D):	$2.06M
Avg Closing Trade (90 D):	$2.75M
Avg Closing Volume:	133.53K

News

Mar 12, 2026 @ 11:00 AM Relmada Therapeutics to Report Fourth Quarter 2025... Source: Na

Feb 26, 2026 @ 5:07 PM Psychedelic Medicine Advances: Here Are Five Compa... Source: Prnewswire

Jul 31, 2025 @ 11:00 AM Relmada Therapeutics to Report Second Quarter 2025... Source: Corporate Communications

Apr 28, 2025 @ 5:38 PM Relmada Therapeutics Presents Positive Initial Pha... Source: N/A

Apr 27, 2025 @ 1:00 PM UPDATE -- Relmada Therapeutics To Present NDV-01 D... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.45	$-.29	$-1.45
Diluted EPS	$-1.45	$-.29	$-1.45
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-57.39M	$-19.87M	$-57.39M
Operating Income / Loss	$-59.1M	$-20.33M	$-59.1M
Cost of Revenue
Net Cash Flow	$-.36M	$2.11M	$-.36M
PE Ratio

Splits
Sep 30, 2019	1:4
Aug 12, 2015	1:5